Kriya Therapeutics , a next generation gene therapy company focused on developing transformative treatments for highly prevalent diseases, announced today that its CEO, Shankar Ramaswamy, M.D., will present at multiple upcoming healthcare conferences in September and October. These includ
| REDWOOD CITY, Calif. and RESEARCH TRIANGLE PARK, N.C., Sept. 3, 2020 /PRNewswire/ -- Kriya Therapeutics, a next generation gene therapy company focused on developing transformative treatments for highly prevalent diseases, announced today that its CEO, Shankar Ramaswamy, M.D., will present at multiple upcoming healthcare conferences in September and October. These include the following: Citi’s 15th Annual BioPharma Virtual Conference H.C. Wainwright & Co. 22nd Annual Global Investment Conference Cantor Fitzgerald Virtual Global Healthcare Conference Chardan 4th Annual Genetic Medicines Conference About Kriya Therapeutics Kriya Therapeutics is a next-generation gene therapy company focused on developing transformative treatments for highly prevalent serious diseases. With core operations in California and North Carolina, Kriya’s technology-enabled platform is directed to the rational design and clinical translation of gene therapies for large patient populations. For more information, please visit www.kriyatx.com. Cautionary Note on Forward-Looking Statements This press release includes forward-looking statements pertaining to our development programs and our proprietary platform. Such forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such statements. The forward-looking statements contained in this press release reflect Kriya’s current views with respect to future events, and Kriya does not undertake and specifically disclaims any obligation to update any forward-looking statements. Contact
SOURCE Kriya Therapeutics |
View original content:
